Showing results (321-330 of 411) with videos related to
Sort By:
Pageof 42
Clinical and Experimental Immunology|March 27, 2014
Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis modelC Andersson, C S Wenander, P A Usher, et al.Anti-Cancer Drugs|August 1, 1991
Phase I evaluation of 773U82.HCl, a member of a new class of DNA intercalatorsK A Havlin, J G Kuhn, J B Craig, et al.International Journal of Radiation Oncology, Biology, Physics|March 1, 1985
Sequential hemibody and local irradiation with combination chemotherapy for small cell lung carcinoma: a preliminary analysisB L Powell, D V Jackson, C W Scarantino, et al.Translational Psychiatry|December 9, 2021
Ibrutinib as a potential therapeutic for cocaine use disorderSpencer B Huggett, Jeffrey S Hatfield, Joshua D Walters, et al.Plos Genetics|May 10, 2012
Using whole-genome sequence data to predict quantitative trait phenotypes in Drosophila melanogasterUlrike Ober, Julien F Ayroles, Eric A Stone, et al.Behavioural Brain Research|January 28, 2014
Long-term behavioral effects of neonatal blockade of gastrin-releasing peptide receptors in rats: similarities to autism spectrum disordersZ Merali, J Presti-Torres, J C Mackay, et al.International Journal of Radiation Oncology, Biology, Physics|April 16, 1998
Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229)C R Thomas, D J Giroux, K J Stelzer, et al.Nature Genetics|September 6, 2003
The genetic architecture of odor-guided behavior in Drosophila: epistasis and the transcriptomeRobert R H Anholt, Christy L Dilda, Sherman Chang, et al.International Journal of Radiation Oncology, Biology, Physics|November 1, 1986
Sequential hemibody irradiation integrated into a chemotherapy-local radiotherapy program for limited disease small cell lung cancerB L Powell, D V Jackson, C W Scarantino, et al.Anti-Cancer Drugs|April 1, 1994
Phase I trial of sulofenur (LY186641) given orally on a daily x 21 scheduleT D Brown, T J O'Rourke, J G Kuhn, et al.Pageof 42